Revance Therapeutics Inc (RVNC)

[jmkobers]

Dew:

It's been > 10 yrs since the last Botox competitor has been FDA approved so the pricing has been static and well established for a long period. With EOLS set for approval next month, any concern they could upset the pricing apple cart a la Amphastar and Enoxaparin? On Jan 10th ValuEngine downgraded RVNC, wonder if if had to do with pending EOLS approval and resulting downward pricing pressure. Some have speculated RVNC will have premium pricing based on duration advantage, but a premium on what is the question.

If EOLS related news isn't pressuring the shares downward, something else seems to be. RVNC has not been participating in the biotech resurgence of late and I don't understand why. Just very little buying interest last few weeks when most biotechs have gone up substantially

Also, a tidbit regarding RVNC option activity, Mostly there is very few purchased call/put lots for all time periods, with the exception being someone bought 1100 25 strike call contracts expiring Feb 19th, which is bullish. Might not mean anything but it is interesting.